These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2890261)

  • 1. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1987 Sep; 131(1):157-8. PubMed ID: 2890261
    [No Abstract]   [Full Text] [Related]  

  • 2. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
    Andén NE; Grabowska-Andén M
    J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for postsynaptic dopamine agonist effects of B-HT 920 in the presence of the dopamine D-1 agonist SKF 38393.
    Meltzer LT; Wiley JN; Williams AE; Heffner TG
    Psychopharmacology (Berl); 1988; 95(3):329-32. PubMed ID: 2901126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1987 Aug; 39(8):660-1. PubMed ID: 2888862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Acta Physiol Scand; 1988 Oct; 134(2):285-90. PubMed ID: 2852446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.
    Hjorth S; Carlsson A
    Psychopharmacology (Berl); 1987; 93(4):534-7. PubMed ID: 2893419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
    Pifl C; Hornykiewicz O
    Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244
    [No Abstract]   [Full Text] [Related]  

  • 8. B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
    Andén NE; Grabowska-Andén M
    J Neural Transm Gen Sect; 1990; 79(3):209-14. PubMed ID: 2136999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor mediated antidepressant action of B-HT 920 in mice.
    Sharma A; Kulkarni SK
    Indian J Exp Biol; 1994 Mar; 32(3):172-5. PubMed ID: 8070836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393.
    Jackson DM; Hashizume M
    Psychopharmacology (Berl); 1986; 90(1):147-9. PubMed ID: 3094056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A; Kulkarni SK
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
    Barone P; Braun AR; Chase TN
    Clin Neuropharmacol; 1986; 9 Suppl 4():128-30. PubMed ID: 2952266
    [No Abstract]   [Full Text] [Related]  

  • 15. Potentiation of dopamine receptor-mediated responses by B-HT 920 in mice.
    Chopra K; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1988; 294():46-55. PubMed ID: 2906798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Peripheral dopaminergic receptor agonists as potential drugs in diseases of the circulatory system].
    Kostowski W
    Pol Tyg Lek; 1985 Dec 23-30; 40(51-52):1448-51. PubMed ID: 2870482
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Regulation of neural transmission in the mouse vas deferens by 2 subtypes of dopaminergic receptors].
    Mitolo-Chieppa D; Carratù MR; De Serio A; Ferrari E; Conte-Camerino D; Damiani M
    Boll Soc Ital Biol Sper; 1988 Aug; 64(8):763-8. PubMed ID: 2850821
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of dopamine receptor stimulation on the motor and stereotypic activities of mice with different genotypes].
    Skrinskaia IuA; Nikulina EM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):549-55. PubMed ID: 1353935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of specific D-1 and D-2 dopamine agonists (LY141865 and SKF-38393) and pergolide on urinary output of rats.
    Leander JD
    Arch Int Pharmacodyn Ther; 1987 Oct; 289(2):290-5. PubMed ID: 2962555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.